Most secretory and membrane proteins present outside of cells are glycosylated. The oligosaccharides attached covalently to asparagine (N-linked) or serine/ threonine (O-linked) of mature proteins have highly diverse structures and are implicated in many extracellular processes. 1) This diversity of oligosaccharides is provided by hundreds of glycosyltransferases in the Golgi complex. On the other hand, the N-linked oligosaccharides attached to newly synthesized polypeptides in the endoplasmic reticulum (ER) are homogenous, relatively simple high-mannose oligosaccharides. High-mannose oligosaccharides are deeply involved in promoting protein folding and quality control, and in the trafficking and sorting of glycoproteins in that they are recognized by specific lectin-type molecules.
2) Of these intracellular events, information on the role of highmannose oligosaccharides as tags for the quality control of proteins has been accumulated.
The ER has a quality control mechanism that discriminates correctly folded proteins from incorrectly folded or incompletely assembled non-functional proteins.
3) Protein folding and oligomer formation are assisted by ER chaperone proteins, and only correctly folded proteins are transported out of the ER to the Golgi complex. Any misfolded proteins are retained in the ER, and they are retro-translocated into the cytosol when misfolding persists, where they are degraded by the proteasome through ubiquitylation. This mechanism is known as ER-associated degradation (ERAD). 4) Recent studies indicate that various ER-resident highmannose oligosaccharide recognition molecules are involved in the several processes of the quality control system, such as individual steps of ER-retention, selection, and targeting of ERAD substrates.
2,5-7)
Fbs1, an F-box protein that recognizes sugar chains 1, specifically binds to the high-mannose oligosaccharides uniquely at the innermost position. 8) Unlike other intracellular oligosaccharide recognition molecules, Fbs1 is present in the cytosol, where glycoproteins rarely exist. Although N-linked glycans are attached in the lumen of the ER or Golgi and are present on the outside of cells or inside vesicular compartments, it has been found that glycosylated molecules become detectable in the cytosol when cytosolic peptide: N-glycanase (PNGase) is knocked down by siRNA, suggesting that glycoproteins are deglycosylated after relocation from the ER into the cytosol. 9) Fbs1 forms the SCF-type E3 ubiquitin ligase complex, and SCF Fbs1 (the superscript denotes the F-box protein) is probably responsible for the ubiquitylation of N-linked glycoproteins through the ERAD pathway. In this article, the discovery and the functions of Fbs1 and related proteins are reviewed.
I. F-Box Proteins
Ubiquitin-mediated proteolysis has a regulatory function in many diverse cellular processes.
10) The ubiquitylation of a specific protein is carried out by the sequential activities of three enzymes, an activating enzyme (E1), an ubiquitin-conjugating enzyme (E2), and an ubiquitin-ligase (E3) (Fig. 1A) . In this ubiquitin pathway, E3 is responsible for the selection of target proteins.
11) E3s constitute a diverse family of proteins and protein complexes. One of the best-characterized families of E3s is the SCF complex, consisting of common components, Skp1, Cul1, and Roc1/Rbx1, as well as variable components known as F-box proteins that bind the substrates (Fig. 1B) . 12, 13) In this complex, the scaffold protein Cul1 interacts at the N-terminus with the adaptor subunit Skp1 and at the C-terminus with the RING-finger protein Roc/Rbx1, which recruits a specific E2 for ubiquitylation. The RING motif was first identified in the early 1990s in the protein encoded by the Really Interesting New Gene 1, 14) and RING finger proteins represent the largest class of potential ubiquitin ligases. F-box proteins, interacting with Skp1 through the approximately 40 amino acid F-box motif, play an indispensable role in the selection of target proteins for degradation, because each distinct F-box protein usually binds a protein substrate(s) with a degree of selectivity for ubiquitylation through C-terminal protein-protein interaction domains. 15) Human and mouse genomes encode 69 and 74 F-box proteins respectively, and a large number of F-box proteins are thought to function in the specific ubiquitylation of a wide range of substrates.
16) The F-box proteins are divided into three classes according to the type of substrate-binding domain. 16) The two classes of binding domains are WD40 and leucine-rich repeats, and hence they are named the Fbw (or FBXW) and Fbl (or FBXL) families respectively. The third class of F-box proteins is the Fbx (or FBXO) family, which does not contain any WD40 repeats or leucine-rich repeats. Most substrates are targeted to SCF E3 ligases after they are covalently modified. While phosphorylation targets numerous substrates to the SCF complex, high-mannose oligosaccharide modification is required for substrate binding by Fbs1 in the SCF complex. Fbs1 belongs to a subfamily consisting of at least five homologous F-box proteins that contain a conserved F-box-associated (FBA) motif at their C-termini. 17, 18) Among these, at least Fbs1 and Fbs2 recognize high-mannose oligosaccharides to form SCF-type ubiquitin ligases.
II. Function of Fbs1
Fbs1 is equivalent to neural F-box protein 42 kDa (NFB42), 19) Fbx2, 17, 20) F-box only protein 2 (FBXO2), Fbg1, 18) and organ of Corti protein 1 (OCP1). 21 ) NFB42 was first isolated from a differential screen to identify cDNAs of PC12 cells induced after the removal of nerve growth factor. 19) NFB42 is expressed in all major areas of the adult rat brain, but not in non-neuronal tissues. Similarly to other F-box proteins, NFB42 interacts with Skp1 through its F-box domain. 17, 19, 20) NFB42 was also A, Most proteins that are degraded in the cytosol are first polyubiquitylated and then degraded by the proteasome. The attachment of ubiquitin (Ub) occurs in several steps. First, Ub is activated by attachment of its carboxy-terminal carboxyl group to a cysteine residue in E1. E1 uses the cleavage of ATP into AMP and PP i for its activation. Second, Ub is transferred to a cysteine residue of an E2. The cells have several E2 enzymes. Third, ubiquitin is transferred to the "-amino group of lysine residues of substrate proteins. This requires E3, which either transiently forms a thiolester with Ub, or allows E2 to transfer the Ub to the substrate. Polyubiquitylation occurs by attachment of extra Ub to lysine residues in Ubs that are already attached. Polyubiquitylated substrates are bound to the proteasome. The polyubiquitin chain is removed by isopeptidases from the substrate before its movement into the proteolytic chamber in the proteasome. B, Structure of SCF complex. In this type E3, the cullin subunit Cul1 functions as a molecular scaffold that simultaneously interacts at the amino terminus with the crucial adaptor subunit, Skp1, and at the carboxyl terminus with a RING-finger protein, Roc1/Rbx1, and a specific E2. Skp1 binds to one of many F-box proteins through the F-box domain.
isolated as the binding partner of the herpes simplex virus 1 (HSV-1) UL9 protein, a viral replication-initiator protein, using a yeast 2-hybrid screen of a HeLa-cell cDNA library. 22) It has been reported that phosphorylated HSV-1 UL9 protein is interacted with NFB42, polyubiquitylated, and then degraded by the proteasome. Although NFB42 is present in the cytosol whereas the UL9 protein is located predominantly in the nucleus, HSV-1 infection promotes nuclear import of NFB42 and NFB42 mediates the nuclear export of the UL9 protein, leading to cytosolic degradation of UL9 protein. 23) Our screening for proteins bound to various glycoproteins led to the identification of Fbs1 from mousebrain extracts.
8) The experiment using a fully reconstituted system showed that Fbs1 can form an SCF complex specific to N-linked glycoproteins. Fbs1 can bind to proteins modified with high-mannose oligosaccharides, which occur in the ER. N-linked glycoproteins are normally not accessible to the ubiquitylation machinery in the cytosol, because they reside within the lumen of the ER and other compartments of the secretory pathway. However, when newly synthesized ER-resident proteins are not folded properly, they are degraded by the ERAD pathway. One of the identified Fbs1 substrates is pre-integrin 1 modified with highmannose oligosaccharides, and their physical association was detected in the cytosol only in the presence of the proteasome inhibitor. 8) Moreover, overexpression of the dominant-negative form Fbs1 lacking the F-box domain essential to the formation of the SCF complex led to inhibition of the degradation of ERAD substrates, suggesting that SCF Fbs1 is involved in the ERAD pathway (Fig. 2) . Indeed, it has been reported that other glycoproteins modified with high-mannose oligosaccharides in the brain 24, 25) are degraded in the ERAD pathway, mediated by SCF Fbs1 . SHP substrate-1 (SHPS-1), a transmembrane glycoprotein that regulates cytoskeletal reorganization and cell-cell communication, is particularly abundant in the central nervous system. Ectopic expression of Fbs1 resulted in elimination of misfolded SHPS-1 molecules from the ER and led to substantial up-regulation of SHPS-1 expression to the cell surface.
24) N-methyl-D-aspartate (NMDA)-type glutamate receptors play a central role in neuronal development and information storage in the mammalian brain. NMDA receptors consist of four subunits, which have a large extracellular domain in their N-terminal. It has been reported that Fbs1 binds to the high-mannose type oligosaccharide of the extracelluar N-terminal domain of one of the NMDA subunits, NR1. Fbs1 mediated neuronal activity-dependent degradation of NR1. 25) Since the sugar moieties on the cell-surface NR1 are high-mannose, it appears possible that the mechanism of Fbs1 regulation of NMDA receptors is due not only to Calnexin and calreticulin, lectin-type chaperones specific for monoglycosylated high-mannose oligosaccharide in the ER, assist in the folding of newly synthesized glycoproteins. Correctly folded glycoproteins can exit the ER to the Golgi complex. Proteins that fail to fold properly or to assemble with their partners are retained in the ER and become a substrate of ER mannosidase I after a certain lag time. Such proteins are recognized by EDEM1, 2, or 3, extracted from the ER into the cytosol, and ubiquitylated by an E3 such as SCF Fbs1 or SCF Fbs2 . The 26S proteasome degrades the glycoprotein after its de-glycosylation by PNGase. The names of N-glycan recognition molecules are boxed.
the ERAD pathway but also to retrograde transfer of endocytosed protein.
Although Fbs1 is known to act as a compartment of SCF-type ubiquitin ligase, the major population of Fbs1 proteins is present as Fbs1-Skp1 heterodimers or Fbs1 monomers but not in SCF Fbs1 . 26) It has been reported that expression of Fbs1 inhibits aggresome formation in Cos7 cells. 8) Moreover, Fbs1 alone has the ability to prevent the aggregation of glycoproteins in vitro. 26) Since the Fbs1 protein is abundant in the nervous system, it appears likely that Fbs1 assists in the clearance of aberrant glycoproteins in neuronal cells by suppressing aggregate formation, independent of ubiquitin ligase activity. Hence, Fbs1 has an additional function as a unique chaperone for those proteins.
Recent study using Fbs1-deficient mice indicates that the Fbs1-Skp1 dimer is essential to inner ear homeostasis.
27) The orthologs of Fbs1 and Skp1 have been identified in the guinea pig as abundant proteins in the organ of Corti, the sensory organ of the cochlea. They are called OCP1 and OCP2 respectively. 21) Mice with targeted deletion of Fbs1 develop age-related hearing loss with cochlear degeneration. The level of the innerear gap junction protein, connexin 26, which has been found to interact with OCP1, 28) increases in Fbs1 À=À mouse cochlear. 27) Furthermore, loss of Fbs1 leads to decrease in cochlear Skp1. On the other hand, the Skp1 level remains unchanged and no defects are seen in Fbs1 À=À mouse brain.
27)

III. Mechanism of Sugar Recognition by Fbs1
Fbs1 and the homologous protein Fbs2 interact with glycoproteins containing high-mannose oligosaccharides. 8, 29) Pull-down analysis using various oligosaccharides revealed that Man 3{9 GlcNAc 2 is required for efficient Fbs1 binding, while modifications of mannose residues by other sugars and deletion of inner GlcNAc reduced its binding, suggesting that it specifically recognizes the inner chitobiose structure in N-glycan.
29)
Indeed, X-ray crystallographic and nuclear magnetic resonance studies of the substrate-binding domain (SBD) of Fbs1 have confirmed that Fbs1 interacts with the innermost chitobiose (GlcNAc-GlcNAc) in N-glycans of glycoproteins by way of a small hydrophobic pocket located at the top of the -sandwich.
30) Furthermore, the introduction of point-mutations into the residues in the small hydrophobic pocket impaired the binding activity of Fbs1 toward its glycoprotein substrates. 30) In general, the internal chitobiose of N-glycans in many native glycoproteins is not accessible by means of macromolecules. Fbs1 interacted with denatured glycoproteins more efficiently than native proteins did, indicating that the innermost position of N-linked oligosaccharides becomes exposed upon protein denaturation and is used as a signal of unfolded glycoproteins to be recognized by Fbs1 (Fig. 3) . 31) However, since ribonuclease B (RNase B) can interact with Fbs1 even in the native form due to the exceptional freedom of the innermost chitobiose moiety, Fbs1 can be purified simply by affinity chromatography using RNase Bimmobilized beads and chitobiose as an eluent.
32)
Recently, the crystal structures of the Skp1-Fbs1 complex and the SBD-RNase B complex were determined.
33)
The structure of the SBD-RNase B complex indicates that the SBD primarily recognizes Man 3 GlcNAc 2 , which is the common structure of all N-glycans. Notably, Fbs1 can bind to glycoproteins modified not only with high-mannose but also with complex oligosaccharides if only the glycoproteins are denatured. 31) Thermodynamic analysis of interactions between synthetic N-linked oligosaccharides and Fbs1 has revealed that Man 3 GlcNAc 2 has the strongest affinity, but that complex oligosaccharides including the Man 3 GlcNAc 2 structure are also capable of binding as well as highmannose oligosaccharides. 34) Since Fbs1 can bind to denatured glycoproteins modified with various N-linked oligosaccharides, it is possible that SCF Fbs1 mediates ubiquitylation of exogenous or membrane proteins endocytosed into the cells. This is not surprising, because it is well known that extracelluar proteins incorporated by phagocytosis into dendritic cells are presented to MHC class I molecules after proteasomal degradation. 35) Other studies have exhibited transfer of endocytosed proteins into the cytosol prior to proteasomal processing of them by unknown mechanisms. 36) Further analysis of Fbs1 and its family of proteins should shed light on the degradation of endocytosed proteins.
IV. ER-Associated Glycoprotein Degradation
The ERAD pathway, consisting of three processes, substrate recognition in the ER, retro-translocation from the ER into the cytosol, and degradation by the ubiquitin-proteasome pathway, plays a major role in the glycoprotein quality control system, which involves various lectin-type molecules in the ER. Newly synthesized polypeptides modified with N-linked oligosaccharides enter co-translationally into the calnexin/calreticulin cycle (Fig. 2) . Both a type-I transmembrane protein calnexin and a soluble protein calreticulin recognize the glucose residue in GlcMan 5{9 GlcNAc 2 .
2,3)
Properly folded or assembled proteins exit from the ER, mediated by ERGIC-53, a type-I membrane mannosebinding lectin that assists in the transport of glycoproteins from the ER to the ER-Golgi intermediate compartment.
3) On the other hand, the improperly folded ones are retained in the ER, and their oligosaccharides are trimmed to Man 8 GlcNAc 2 by ER -mannosidase I. Proteins modified with Man 8 GlcNAc 2 are believed to be released from the calnexin/calreticulin cycle by the action of EDEM/Htm1p/MnlIp protein (yeast proteins are denoted Xxxp) (Fig. 2) . 7) Mammalian EDEM and its yeast Saccharomyces cerevisiae ortholog Htm1p/MnlIp have been reported to be proteins with an ERmannosidase I-like domain, but they lack enzyme activity. Recently, two novel EDEM paralogs, EDEM2 and EDEM3, have been reported in mammals. [37] [38] [39] Expression of EDEM1-3 is induced by ER-stress and overexpression of these proteins accelerates the ERAD of glycoprotein, but it remains to be established whether EDEM proteins bind specific N-linked oligosaccharides. While yeast has no paralog of Htm1p, a new type of lectin, Yos9p, showing similarity to mannose-6-phosphate receptors, [40] [41] [42] [43] is perhaps to bind glycoproteins carrying Man8 and Man5 N-linked oligosaccharide in yeast. 43) It has been reported that proteins are targeted to an appropriate ERAD pathway depending on the site of the misfolded lesion. Membrane and soluble proteins with luminal lesions are targeted to the ERAD-L pathway, whereas membrane proteins with misfolded cytoplasmic domains use the ERAD-C pathway. 44) In yeast, two ERassociated E3 ubiquitin ligases, Hrd1p/Der3p and Doa10p, are involved in the ERAD pathway. Hrd1p is used by the ERAD-L pathway, while Doa10p is involved in the ERAD-C pathway. Yos9p associates with the core ERAD machinery, including Hrd1p at the ER membrane. 45, 46) After targeting to the ERAD machinery, substrate proteins cross the ER membrane. It was believed that this occurs through the Sec61 channel, which is used for co-and post-translational translocation, but recently it was reported that several other ER transmembrane proteins are required for retro-translocation from the ER to the cytosol. US2 and US11, glycoproteins encoded by the human cytomegalovirus genome, induce retro-translocation of class I major histocompatiblity complex (MHC) molecules from the ER and target them for proteasomal degradation. 47) It has been reported that Derlin-1 is essential for extraction of US11 to the cytosol and that it interacts with the p97/VCP/Cdc48 complex (p97-Npl4-Ufd1). 48, 49) In ERAD, protein ubiquitylation participates in both protein extraction from the ER and subsequent proteasomal protein degradation, and p97 complex is required for the release of ERAD substrates from the ER. 50) On the other hand, signal peptide peptidase has been identified as a key component in the dislocation of US2.
51) It has also been reported that Derlin-2 and 3, homologous proteins of Derlin-1, are required for degradation of the null Hong Kong mutant of 1-antitrypsin, one of the ERAD substrate glycoproteins, and that they are associated with EDEM and p97. 52) The SCF Fbs1 and SCF Fbs2 confer substrate specificity for ubiquitlylation of high-mannose oligosaccharide modified proteins, although Fbs1 is restrictly expressed in adult brain while Fbs2 is ubiquitously expressed. 8, 29) A population of these E3 ubiquitin ligases is associated with p97 on the ER membrane. 31) The ER-associated E3s recognize high-mannose oligosaccharides of the retro-translocated proteins and ubiquitylate the glycoproteins, and this might facilitate its binding to p97 complex as well as its extraction from the ER.
High-mannose oligosaccharides can thus serve not only as targeting signals for the ERAD pathway in the ER but also as degradation signals in the cytosol. Finally, the oligosaccharides are removed by PNGase before delivery to the proteasome, 53, 54) but degradation of class-I MHC molecules proceeds even when PNGase is completely inhibited, suggesting that PNGase functions to facilitate more efficient proteasomal degradation of glycoproteins through removal of glycan.
55)
V. Fbs Family
Besides Fbs1, at least four F-box proteins that show high homology in SBD have been reported. 17, 18) These F-box proteins are composed of a highly homologous Fbox domain, a substrate-binding domain, and a low homologous short linker sequence between F-box and SBD (Figs. 4A and 5) . Although the homologies between Fbs2 and Fbg3 and between Fbg4 and Fbg5 in the short linker sequence are high, the linker sequence of Fbs1 shows no homology to any of them. It has been 1 : MDGDGDPESV GQPEEASPEE QPEEASAEEE RPEDQQEEEA AAAAAYLDEL PEPLLLRVLA 1 : **---A*H*-------------------------------K**LDSIN** **NI**ELFT 1 : *-----------------------------------------*VGNIN** **NI**ELFT 1 : *---*ARL*--------------------------RRRLP *DPSLA**A* *PE**VQ**S 1 : *---*ASV*R *---R*ARVP A**--------**---P**----*LD*SQ* *PE***V**S 61 : ALPAAELVQA CRLVCLRWKE LVDGAPLWLL --------------KCQQEG LVPEGGVEEE 27 : HV**RQ*LLN *****SL*RD *I*LMT**KR --------------**LR** FITKDWDQPV 20 : HV**RQ*LLN *****SL*RD *I*LVT**KR --------------**LR** FITEDWDQPV 32 : HV*PRS**TR **P**RA*RD I***PTV*** QLARDRSAEG RALYAVA*RC *PSNEDK**F 40 : HV*PRT*LGR **Q**RG*RA ****QA**** ILARDHGATG RALLH-LARS CQSPARNAR-107 : RDHWQQFYFL -SKRRRNLLR NPCGEEDLEG WCDVEHGGDG WRVE-ELPGD SGVEFTHDES 73 : A*-*KI**** -RSLH***** ***A***MFA *QIDFN***R *K**-S**GA H*TD*-P*PK 66 : A*-*KI**** -RSLH****H ***A**GF*F *SLDVN***E *K**-D*SR* QRK**PN*-Q 92 : PLCALAR*C* RAPFG***IF *S***QGFR* *-E*E***N* *AI*KN*TPV P*------AP 98 : PCPLGR*CAR R-PIG***I* ****Q*G*RK *-M*Q***** *V**-*----NRTTVPGAP* 165 : VKKYFASSFE WCRKAQVIDL QAEGYWEELL DTTQPAIVVK DWYSGRSDAG CLYELTVKLL 129 : *****VT*Y* M*L*S*LV** V********L **FR*D**** **FAARA*C* *T*Q*K*Q*A 122 : *****VT*YY T*L*S**V** K********M ***R*D*E** **FAA*P*C* SK*Q*C*Q** 145 : SQTC*VT*** **S*R*LV** VM**V*Q*** *SA*IE*C*A **WGA*ENC* *V*Q*R*R** 154 : -QTC*VT**S **C*K**L** EE**L*P*** *SGRIE*C*S **WGA*H*S* *M*R*L*Q** reported that the inefficient SCF complex formation of Fbs1 and the restricted presence of SCF Fbs1 bound to the ER membrane are due to the short linker sequence. 26) Human Fbs1/Fbg1/Fbx2/NFB42, Fbs2/Fbg2/Fbx6b, Fbg3/Fbx44, Fbg4/Fbx17, and Fbg5/Fbx27 proteins have 46, 12, 5, 17, and 25 additional amino acid sequences respectively in their diverse N-termini next to the F-box domain (Fig. 5) . In addition, the N-terminal regions of Fbs1 and Fbg5 satisfy the criteria for strong and weak PEST domains, which are characteristic of proteins with short half-lives respectively. 18, 56) It has been reported that the U-box type E3 C-terminus of Hsc70-interacting protein (CHIP) is associated with Fbs1 through the PEST domain. 56) Recently, we reported that this unique N-terminal region of Fbs1 is required for in vitro aggregation suppressing activity. 26) Furthermore, both human and mouse Fbs2 proteins contain additional C-terminal regions with no homology. The amino acid sequences of these Fbs family members show 32-65% overall identity to one another, and their identities are 39-68% in SBD (Table 1 ). In particular, the amino acid identities in SBD between the Fbs2 and Fbg3 proteins and between the Fbg4 and Fbg5 proteins are more than 60%. These F-box proteins cluster into two groups on the basis of phylogenetic analysis: one group is composed of Fbs1, Fbs2, and Fbg3, and the other of Fbg4 and Fbg5. 17) In the human and mouse genomes, these two groups of genes are located separately, but the genes in each group are arranged in tandem with very short intergenic regions. The Fbs1, Fbs2, and Fbg3 genes are localized on human chromosome 1p36.11-36.23 and on mouse chromosome 4E2, and the Fbg4 and Fbg5 genes are on human 19q13.2 and mouse 7B1.
F-box
In the NCBI database Entrez gene, Fbs1, Fbs2, and Fbg5 encode single proteins, but Fbg3 and Fbx17 encode two proteins. Although Fbx17 encodes two proteins whose differences lie only in their N-terminal 9 amino acids by the different use of the first exon, Fbg3 encodes proteins non-homologous in their SBDs (isoform1 and isoform2). The Fbg3 isoform1 protein is translated without skipping exons and shows high identity with Fbs2, as shown in Figs. 4 and 5. On the other hand, Fbg3 isoform2 is synthesized by skipping the 4th exon, and the resulting protein contains the 255 amino-acid region, which is different from C-terminal half of isoform1 (after residue-123).
The expression of Fbs1, Fbg4, and Fbg5 is tissuespecific, but that of Fbs2 and Fbg3 is relatively ubiquitous. 18, 29) Fbs1 is strongly expressed in neural cells in the adult brain and weakly in the testis. Fbg4 expression is predominant in the kidney and weak in the liver. Fbg5 is detected in the brain, heart, kidney, and liver.
Despite the high homology between Fbs2 and Fbg3, no sugar-binding activity of Fbg3 has been detected. Of the Fbs family members, Fbs1 has the ability to bind strongly to the high-mannose oligosaccharides-modified proteins, while Fbs2 and Fbg5 bind them more weakly (refs. 8, 29, 56 and our unpublished data), but we did not detect any sugar-binding activity for Fbg3 and Fbg4 even though we used several assay systems. X-ray crystallographic study of the substrate-binding domain of Fbs1 has revealed that Fbs1 interacts with the innermost chitobiose of glycoproteins by Phe177, Tyr279, Try280, and Lys281 on the loop structures in mouse Fbs1 and in human Fbs1, Phe173, Tyr278, Trp279, and Lys280, as shown in Fig. 5 . 30) Among these residues, the Phe177Ala, Tyr2798Ala, or Trp280Ala mutants lost the ability to interact with glycoproteins. The alignment of human Fbs1 and its homologs shows that these residues, except for Lys280, are conserved in Fbs1, Fbs2, Fbg3, and Fbg5. It is anticipated that Fbg4 does not interact with the chitobiose moiety, because the residue corresponding to Tyr278 of human Fbs1 is serine in Fbg4, but these four residues are conserved in Fbs2 and Fbg3. Further analysis of the structure of the substrate-binding domain of Fbs2 and Fbg3 is needed to elucidate the mechanism by which Fbg3 fails to bind to chitobiose.
VI. Conclusions and Perspectives
Fbs1 is an F-box protein abundantly present in the adult brain. It recognizes N-glycans at the innermost position as a signal for unfolded glycoproteins, probably in the ERAD pathway. On the other hand, Fbs2, another glycoprotein-specific F-box protein, is distributed in a variety of cells and tissues. Considering the general importance of these F-box proteins in the ERAD pathway, the restricted expression of Fbs1 in neurons remains a mystery. Unlike other F-box proteins, Fbs1 appears to have a dual function in both the SCF and the non-SCF complex due to the short, unconserved linker sequence between the F-box domain and the sugarbinding domain. It assists in the clearance of aberrant glycoproteins in neuronal cells by chaperone activity in addition to its ubiquitin ligase activity. Further studies aimed at identifying Fbs1-targeted glycoprotein and Fbs1-interacted proteins in the brain will probably reveal important roles of Fbs1 in cellular homeostasis. Although Fbs1, Fbs2, and Fbg5 have similar abilities to bind to glycoproteins modified with high-mannose oligosaccharide, they have different potencies of binding to glycoproteins. To gain insight into the differences in their mechanisms for oligosaccharide recognition related to their cellular functions, further structural and biological analysis is required. Moreover, it would be intriguing to identify the substrates for Fbg3 and Fbg4, which are not capable of binding to glycoproteins. Such analysis is clearly necessary for a better understanding of the overall functions of Fbs family proteins in vivo.
